<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 1 Issue 2</issue_number>
<issue_period>2010 (April - June) </issue_period>
<title>Toxicity Studies of Oxy Powder®-Revised</title>
<abstract>The objective of this study was to assess the toxic effects of Oxy powder® in-vitro on four pathogenic microbes and a probiotic bacterium generally present in the human GI tract and to determine acute oral toxicity (LD50) profile of Oxy Powder® in Sprague Dawley rats. The results shall be used in selecting doses in repeated dose toxicity study of Oxy Powder. </abstract>
<authors>Jogender K. Lalla,Lalla,Meena U. Shah,Edward F. III Group</authors>
<keywords>GHCâ€™s Oxy PowderÂ®, Dietary supplement â€“ In vitro Toxicity to Microbes â€“ Acute oral (LD50) Toxicity in Sprague Dawley Rats. </keywords>
<pages>-</pages>
</article>
</Journal>
